Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
Conditions: Relapsed Follicular Lymphoma; Refractory Follicular Lymphoma Interventions: Drug: Epcoritamab; Drug: Lenalidomide; Drug: Rituximab; Drug: Obinutuzumab; Drug: Bendamustine; Drug: Vincristine; Drug: Doxorubicin; Drug: Cyclophosphamide; Drug: Prednisone; Drug: Investigation agent 2; Drug: Investigation agent 3 Sponsors: University of Birmingham; Cancer Research UK; Genmab Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma
Condition: Hodgkin Lymphoma Interventions: Drug: Prolgolimab; Drug: Combination with prolgolimab and bendamustine Sponsors: St. Petersburg State Pavlov Medical University; N.N. Petrov National Medical Research Center of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2023 Category: Research Source Type: clinical trials
